BETHESDA, Md. (Apr. 28, 2026) A researcher with Naval Medical Research Command’s (NMRC) Clinical Trials Center (CTC) holds a self-administered nasal spray called INNA-051, designed to prevent and reduce symptoms of viral respiratory infections like the common cold or flu. The CTC is preparing a study into the effectiveness of INNA-051, planned to begin in September. NMRC, headquarters of Navy Medicine Research & Development, is engaged in a broad spectrum of activity from basic science in the laboratory to field studies in austere and remote areas of the world to investigations in operational environments. In support of Navy, Marine Corps, and joint U.S. warfighter health, readiness and lethality, researchers study infectious diseases, biological warfare detection and defense, combat casualty care, environmental health concerns, aerospace and undersea medicine, operational mission support and epidemiology. (U.S. Navy photo by Sidney Hinds /Released)
| Date Taken: | 04.28.2026 |
| Date Posted: | 06.01.2026 14:18 |
| Photo ID: | 9718464 |
| VIRIN: | 260428-N-UM734-1014 |
| Resolution: | 4228x6342 |
| Size: | 2.36 MB |
| Location: | BETHESDA, MARYLAND, US |
| Web Views: | 4 |
| Downloads: | 0 |
This work, NMRC CTC Prepares for Trials of Respiratory Infection Treatment [Image 4 of 4], by Tommy Lamkin, identified by DVIDS, must comply with the restrictions shown on https://www.dvidshub.net/about/copyright.
No keywords found.
